Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2003

View Archived Issues

BMP-7 implants in lumbar fusion

Potential role for antileukotriene agents in the treatment of late-stage atherosclerosis

No association found for inhaled corticosteroids and a lower BMD in postmenopausal women

NPS and Enzon agree to merger of equals

Novo Nordisk claims new purine-based DPP-IV inhibitors

Novel chemokine CCR3 modulators and their use in asthma and rhinitis

Vertex scientists design novel inhibitors of Src and/or Lck kinases

Novel DPP-IV inhibitors in early development at Merck

New erythromycin antibiotics prepared and tested at Chiron

Alphav integrin antagonists and their use disclosed by 3DP

Active Biotech presents new immunomodulators targeting the CD80/CD28 interaction

NeuroSearch describes modulators of nicotinic receptors and/or monoamine transporters

Advexin awarded orphan drug designation

Biopure receives additional funding to develop Hemopure for trauma applications

Results from phase III Surfaxin trial will be delayed several months

Enrollment temporarily suspended in phase III studies of tariquidar

Promising results reported for Targretin in chronic severe hand dermatitis

KS Biomedix reviews half-year milestones

Ono-4817 plus docetaxel inhibits lung micrometastasis of MMP-expressing tumor cells in nude mice

SB-203580 induces p38 MAP kinase-independent differentiation of leukemia cells

AVI-4126 increases sensitivity of lung tumors to conventional chemotherapeutic agents

New antiinflammatory role proposed for statins

Nonthiazolidinedine antidiabetic agent with favorable pharmacological and pharmacokinetic profile

First Chugai product licensed by Roche for codevelopment/copromotion

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...